Weicheng Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Weicheng Chan has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Yuan Yue
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology Sichuan University Chengdu Sichuan China
3 shared publications - Jiajia Wang
Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2 shared publications - Liang Hao
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, Department of Prosthodontics, West China Hospital of Stomatology, Sichuan University
2 shared publications Min Wang
The State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases Department of Prosthodontics West China Hospital of Stomatology Sichuan University Chengdu China
2 shared publications- Jiaan-Der Wang
Center for Rare Disease and Hemophilia, Taichung Veterans General Hospital, Taichung, Taiwan
1 shared publication Jie Liu
Stomatology Hospital School of Stomatology Zhejiang University School of Medicine Clinical Research Center for Oral Diseases of Zhejiang Province Key Laboratory of Oral Biomedical Research of Zhejiang Province Cancer Center of Zhejiang University Hangzhou China
1 shared publication
Latest Publications
- 30 July 2023
- Published by Wiley in Oral Diseases
- Vol. 30 (4) , 2485-2496
Activation of receptor‐interacting protein 3‐mediated necroptosis accelerates periodontitis in mice
Objective: To investigate the involvement and role of receptor‐interacting protein 3 (RIP3)‐mediated necroptosis in periodontitis.Methods: A periodontitis murine model was established by oral infection with Porphyromonas gingivalis, and activation of necroptosis pathway was identified by immunohistochemistry. Adeno‐associated virus was used to knock down Rip3 and the effect of Rip3 knockdown on periodontal inflammation was examined by Micro‐CT, qRT‐PCR and histological staining. In vitro, P. gingivalis‐LPS was used to infect fibroblast cell line L929 and siRNA was used to knock down Rip3. Necroptosis pathway signalling and inflammation in cells were detected by cell viability and death assay, Western Blot, qRT‐PCR and immunofluorescence analysis.Results: Phosphorylation of RIP3 and mixed lineage kinase domain‐like protein (MLKL) was increased in the periodontal ligament of mice infected with P. gingivalis. RIP3 knockdown reduced osteoclastogenesis and inflammatory cytokines in the periodontal area, and alleviated alveolar bone loss in vivo. In vitro, P. gingivalis‐LPS‐induced RIP3‐mediated necroptosis in L929 cells, and knockdown of RIP3 by siRNA decreased the expression of inflammatory cytokines.Conclusion: RIP3‐mediated necroptosis is activated in periodontitis and blocking necroptosis alleviates disease progression, indicating that RIP3 may be a potential target for periodontitis treatment.
- 30 July 2023
- Published by Wiley in Oral Diseases
- Vol. 30 (4) , 2485-2496
Activation of receptor‐interacting protein 3‐mediated necroptosis accelerates periodontitis in mice
Objective: To investigate the involvement and role of receptor‐interacting protein 3 (RIP3)‐mediated necroptosis in periodontitis.Methods: A periodontitis murine model was established by oral infection with Porphyromonas gingivalis, and activation of necroptosis pathway was identified by immunohistochemistry. Adeno‐associated virus was used to knock down Rip3 and the effect of Rip3 knockdown on periodontal inflammation was examined by Micro‐CT, qRT‐PCR and histological staining. In vitro, P. gingivalis‐LPS was used to infect fibroblast cell line L929 and siRNA was used to knock down Rip3. Necroptosis pathway signalling and inflammation in cells were detected by cell viability and death assay, Western Blot, qRT‐PCR and immunofluorescence analysis.Results: Phosphorylation of RIP3 and mixed lineage kinase domain‐like protein (MLKL) was increased in the periodontal ligament of mice infected with P. gingivalis. RIP3 knockdown reduced osteoclastogenesis and inflammatory cytokines in the periodontal area, and alleviated alveolar bone loss in vivo. In vitro, P. gingivalis‐LPS‐induced RIP3‐mediated necroptosis in L929 cells, and knockdown of RIP3 by siRNA decreased the expression of inflammatory cytokines.Conclusion: RIP3‐mediated necroptosis is activated in periodontitis and blocking necroptosis alleviates disease progression, indicating that RIP3 may be a potential target for periodontitis treatment.
- 10 June 2022
- Published by Wiley in Oral Diseases
- Vol. 29 (5) , 1927-1936
A significant other: Non‐canonical caspase‐4/5/11 inflammasome in periodontitis
Periodontitis is an oral inflammatory disease characterised by the destruction of periodontal soft tissue and alveolar bone resorption, mainly triggered by plaque microbial infection. Pyroptosis is an inflammatory form of programmed cell death mediated by the pore‐forming gasdermin proteins, which resist the invasion of pathogens into the body's immune system. Many studies have found that pyroptosis is closely related to the occurrence and development of periodontitis. At present, most of these studies focused on the canonical pathway mediated by caspase‐1. Moreover, Gram‐negative bacteria's lipopolysaccharide has been shown to activate a new form of the non‐canonical inflammasome by directly binding to human caspase‐4/5 and mouse caspase‐11 in the cytosol. However, most of the functions of non‐canonical inflammasome are still gradually being studied. Therefore, in this review, we have summarised and analysed the existence and regulation mechanism of the non‐canonical inflammasome in periodontitis.
- 10 June 2022
- Published by Wiley in Oral Diseases
- Vol. 29 (5) , 1927-1936
A significant other: Non‐canonical caspase‐4/5/11 inflammasome in periodontitis
Periodontitis is an oral inflammatory disease characterised by the destruction of periodontal soft tissue and alveolar bone resorption, mainly triggered by plaque microbial infection. Pyroptosis is an inflammatory form of programmed cell death mediated by the pore‐forming gasdermin proteins, which resist the invasion of pathogens into the body's immune system. Many studies have found that pyroptosis is closely related to the occurrence and development of periodontitis. At present, most of these studies focused on the canonical pathway mediated by caspase‐1. Moreover, Gram‐negative bacteria's lipopolysaccharide has been shown to activate a new form of the non‐canonical inflammasome by directly binding to human caspase‐4/5 and mouse caspase‐11 in the cytosol. However, most of the functions of non‐canonical inflammasome are still gradually being studied. Therefore, in this review, we have summarised and analysed the existence and regulation mechanism of the non‐canonical inflammasome in periodontitis.
- 4 February 2022
- Published by Wiley in Oral Diseases
- Vol. 29 (4) , 1802-1811
Inhibition of Rgs10 aggravates periodontitis with collagen‐induced arthritis via the nuclear factor‐κB pathway
Objective: To explore the role of the Rgs10‐associated nuclear factor (NF)‐κB signalling pathway in periodontitis with rheumatoid arthritis.Methods: Porphyromonas gingivalis and collagen were locally applied to mice to establish in vivo periodontitis and rheumatoid arthritis models, respectively. Both agents were administered together to establish the comorbid group. All models were treated with adeno‐associated virus‐green fluorescent protein (AAV‐GFP) or adeno‐associated virus small hairpin Rgs10 (AAV‐sh‐Rgs10). In vivo expression of Rgs10 and inflammatory cytokines was analysed, along with exploration of the NF‐κB signalling pathway in lipopolysaccharide‐stimulated mouse‐derived RAW264.7 cells, with and without treatment of small interfering RNA (siRNA; Rgs10‐Mus‐MSS245072).Results: In the comorbidity mouse group (mice with both periodontitis and rheumatoid arthritis), inhibition of Rgs10 exacerbated periodontitis, along with upregulation of phospho‐RelA (pP65), tumour necrosis factor‐α (TNF‐α) and interleukin‐6 (IL‐6) expression in the NF‐κB signalling pathway. Similarly, treatment of LPS‐stimulated RAW264.7 cells with siRNA resulted in the inhibition of Rgs10, along with upregulation of pP65, TNF‐α and IL‐6 expression in vitro.Conclusion: Inhibition of Rgs10 in mice with periodontitis and rheumatoid arthritis can promote the progression of periodontitis, indicating the potential therapeutic role of Rgs10 in this condition.
- 4 February 2022
- Published by Wiley in Oral Diseases
- Vol. 29 (4) , 1802-1811
Inhibition of Rgs10 aggravates periodontitis with collagen‐induced arthritis via the nuclear factor‐κB pathway
Objective: To explore the role of the Rgs10‐associated nuclear factor (NF)‐κB signalling pathway in periodontitis with rheumatoid arthritis.Methods: Porphyromonas gingivalis and collagen were locally applied to mice to establish in vivo periodontitis and rheumatoid arthritis models, respectively. Both agents were administered together to establish the comorbid group. All models were treated with adeno‐associated virus‐green fluorescent protein (AAV‐GFP) or adeno‐associated virus small hairpin Rgs10 (AAV‐sh‐Rgs10). In vivo expression of Rgs10 and inflammatory cytokines was analysed, along with exploration of the NF‐κB signalling pathway in lipopolysaccharide‐stimulated mouse‐derived RAW264.7 cells, with and without treatment of small interfering RNA (siRNA; Rgs10‐Mus‐MSS245072).Results: In the comorbidity mouse group (mice with both periodontitis and rheumatoid arthritis), inhibition of Rgs10 exacerbated periodontitis, along with upregulation of phospho‐RelA (pP65), tumour necrosis factor‐α (TNF‐α) and interleukin‐6 (IL‐6) expression in the NF‐κB signalling pathway. Similarly, treatment of LPS‐stimulated RAW264.7 cells with siRNA resulted in the inhibition of Rgs10, along with upregulation of pP65, TNF‐α and IL‐6 expression in vitro.Conclusion: Inhibition of Rgs10 in mice with periodontitis and rheumatoid arthritis can promote the progression of periodontitis, indicating the potential therapeutic role of Rgs10 in this condition.
- Open Access
- 13 September 2018
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 24 (9_suppl) , 163S-170S
Comparison of Total Joint Replacement Rate Between Patients With Hemophilia A and Patients With Hemophilia B: A Population-Based and Retrospective Cohort Study
Recurrent hemarthrosis in patients with hemophilia (PWH) results in chronic arthropathy requiring total joint replacement (TJR). This study aimed to compare the difference in TJR rate between patients with hemophilia A (HA) and hemophilia B (HB). A final total of 935 PWH (782 HA and 153 HB) without inhibitors were collected from the Taiwan’s National Health Insurance Research Database between 1997 and 2013. Demographics, clinical characteristics, and TJR rate were compared between the 2 groups. The annual use of clotting factor concentrate was not different between HA and HB groups (P = .116). The rate of comorbidities except for 29 PWH having HIV who were all in the HA group was also not different between the 2 groups. A total of 99 (10.6%) PWH had undergone 142 TJR procedures during the study period. All of them had received on-demand therapy. No difference was found in the cumulative incidence of TJR between HA and HB (P = .787). After adjusting for various confounders including age, pyogenic arthritis, and HIV infection, no increased risk of TJR was found in patients with HA versus Patients with HB (hazard ratio: 0.92, 95% confidence interval 0.54-1.58). This finding suggests that the rate of TJR between patients with HA and HB is not significantly different.
- 13 September 2018
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 24 (9_suppl) , 163S-170S
Open AccessComparison of Total Joint Replacement Rate Between Patients With Hemophilia A and Patients With Hemophilia B: A Population-Based and Retrospective Cohort Study
Recurrent hemarthrosis in patients with hemophilia (PWH) results in chronic arthropathy requiring total joint replacement (TJR). This study aimed to compare the difference in TJR rate between patients with hemophilia A (HA) and hemophilia B (HB). A final total of 935 PWH (782 HA and 153 HB) without inhibitors were collected from the Taiwan’s National Health Insurance Research Database between 1997 and 2013. Demographics, clinical characteristics, and TJR rate were compared between the 2 groups. The annual use of clotting factor concentrate was not different between HA and HB groups (P = .116). The rate of comorbidities except for 29 PWH having HIV who were all in the HA group was also not different between the 2 groups. A total of 99 (10.6%) PWH had undergone 142 TJR procedures during the study period. All of them had received on-demand therapy. No difference was found in the cumulative incidence of TJR between HA and HB (P = .787). After adjusting for various confounders including age, pyogenic arthritis, and HIV infection, no increased risk of TJR was found in patients with HA versus Patients with HB (hazard ratio: 0.92, 95% confidence interval 0.54-1.58). This finding suggests that the rate of TJR between patients with HA and HB is not significantly different.